These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
645 related items for PubMed ID: 28882733
1. [Risk of fatal/non-fatal events in patients with previous coronary heart disease/acute myocardial infarction and treatment with non-steroidal anti-inflammatory drugs]. Muñoz Olmo L, Juan Armas J, Gomariz García JJ. Semergen; 2018; 44(5):355-363. PubMed ID: 28882733 [Abstract] [Full Text] [Related]
3. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF, Hsiao FY, Wen YW, Tsai YW. Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [Abstract] [Full Text] [Related]
4. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM. Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734 [Abstract] [Full Text] [Related]
5. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Hernández-Díaz S, Varas-Lorenzo C, García Rodríguez LA. Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201 [Abstract] [Full Text] [Related]
7. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Drug Saf; 2006 Mar; 29(7):621-32. PubMed ID: 16808554 [Abstract] [Full Text] [Related]
9. Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis. Barcella CA, Lamberts M, McGettigan P, Fosbøl EL, Lindhardsen J, Torp-Pedersen C, Gislason GH, Olsen AS. Basic Clin Pharmacol Toxicol; 2019 May; 124(5):629-641. PubMed ID: 30484960 [Abstract] [Full Text] [Related]
10. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. BMJ; 2017 May 09; 357():j1909. PubMed ID: 28487435 [Abstract] [Full Text] [Related]
13. Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence. Shau WY, Chen HC, Chen ST, Chou HW, Chang CH, Kuo CW, Lai MS. BMC Cardiovasc Disord; 2012 Feb 02; 12():4. PubMed ID: 22297085 [Abstract] [Full Text] [Related]
14. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rahme E, Nedjar H. Rheumatology (Oxford); 2007 Mar 02; 46(3):435-8. PubMed ID: 17255138 [Abstract] [Full Text] [Related]
20. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E, Watson DJ, Kong SX, Toubouti Y, LeLorier J. Pharmacoepidemiol Drug Saf; 2007 May 02; 16(5):493-503. PubMed ID: 17086567 [Abstract] [Full Text] [Related] Page: [Next] [New Search]